MedTrace Logo

Enhancing Resilience in Senior Living Community Residents

NCT04720014 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-09-09

No results posted yet for this study

Summary

This single-arm pilot study tests the feasibility of integrating the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP), a mind-body intervention, into senior living residential communities. The investigators hypothesize that the SMART-3RP intervention will be feasible for senior living community residents to attend.

Conditions

  • Stress, Psychological
  • Coping Skills

Interventions

BEHAVIORAL

SMART-3RP Group Intervention

Nine 1.5 hour group sessions focusing on developing: 1. an understanding of stress physiology and the physiology of the relaxation response; 2. a regular practice of eliciting the relaxation response; and 3. cognitive behavioral and positive psychology/resilience skills. Participants receive a copy of the SMART-3RP session manual and audio recorded guided meditations for independent relaxation practice. Participants are encouraged to practice eliciting the relaxation response daily throughout the study, using the audio recordings or other mind body techniques. Participants will use a practice log to track their practice.

Sponsors & Collaborators

  • Erickson Living Management, LLC

    collaborator UNKNOWN

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Lara Traeger, Ph.D · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-30
Primary Completion
2021-09-20
Completion
2021-09-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04720014 on ClinicalTrials.gov